<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-TUZ8OFGX</identifier><date>2021</date><creator>Banjac, Marta</creator><creator>Blatnik, Ana</creator><creator>Hotujec, Simona</creator><creator>Klopčič, Natalija</creator><creator>Krajc, Mateja</creator><creator>Novaković, Srdjan</creator><creator>Ocvirk, Janja</creator><creator>Strojnik, Ksenija</creator><relation>documents/doc/T/URN_NBN_SI_doc-TUZ8OFGX_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TUZ8OFGX_001.txt</relation><format format_type="extent">4 str., 30 cm</format><format format_type="type">e-knjige</format><identifier identifier_type="COBISSID_HOST">54881539</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TUZ8OFGX</identifier><language>slv</language><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><source>knjige</source><rights>InC</rights><subject language_type_id="slv">genetika</subject><subject language_type_id="slv">genetsko testiranje</subject><subject language_type_id="slv">klinične poti</subject><subject language_type_id="slv">rak prostate</subject><title>Prednostno genetsko testiranje na zarodne mutacije pri bolnikih z metastatskim rakom prostate/pankreasa/dojk, ki potrebujejo izvid za zdravljenje raka s PARP inhibitorji</title></Record>